Kim Ho-Cheol, Choi Sang-Ho, Huh Jin-Won, Sung Heungsup, Hong Sang Bum, Lim Chae-Man, Koh Younsuck
Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
J Med Virol. 2016 Dec;88(12):2092-2099. doi: 10.1002/jmv.24577. Epub 2016 May 30.
Respiratory viruses are well-known causes of acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and also important pathogens for concomitant pneumonia in COPD (CP-COPD). However, the differences in a viral infection pattern and clinical impacts of respiratory viruses between the two groups have not been well investigated. The clinical and microbiological data from COPD patients admitted with AE-COPD (n = 281) or CP-COPD (n = 284) between January 2010 and December 2012 were reviewed. After excluding 88 patients (40 with AE-COPD and 48 with CP-COPD) who did not undergo a multiplex RT-PCR test for respiratory viruses, the demographic characteristics, identified viruses, and clinical outcomes of the AE-COPD and CP-COPD groups were compared. Respiratory viruses were identified in 41.9% of AE-COPD group and 33.5% of the CP-COPD groups. The most common virus was influenza virus in the AE-COPD group (33.7%) versus human coronavirus (24.1%) in the CP-COPD group. Influenza virus was significantly more common in the AE-ACOPD group than in the CP-COPD group (P < 0.01). In-hospital mortality of AE-COPD and CP-COPD were 1.2% and 12.3%, respectively (P < 0.01). Among CP-COPD patients, in-hospital mortality of patients with only viral infection group, only bacterial infection group, and viral-bacterial co-infection were 2.6%, 25.8%, and 17.5%, respectively (P = 0.01). Respiratory viruses were commonly identified in both AE-COPD and CP-COPD, influenza virus and human coronavirus were the most common viruses identified in AE-COPD and CP-COPD patients, respectively. The mortality rates of only viral infection group was significantly lower than only bacterial infection or viral-bacterial co-infection group in CP-COPD patients. J. Med. Virol. 88:2092-2099, 2016. © 2016 Wiley Periodicals, Inc.
呼吸道病毒是慢性阻塞性肺疾病急性加重(AE-COPD)的常见病因,也是慢性阻塞性肺疾病合并肺炎(CP-COPD)的重要病原体。然而,两组之间呼吸道病毒的感染模式和临床影响差异尚未得到充分研究。回顾了2010年1月至2012年12月期间因AE-COPD(n = 281)或CP-COPD(n = 284)入院的慢性阻塞性肺疾病患者的临床和微生物学数据。在排除88例未接受呼吸道病毒多重RT-PCR检测的患者(40例AE-COPD患者和48例CP-COPD患者)后,比较了AE-COPD组和CP-COPD组的人口统计学特征、鉴定出的病毒及临床结局。在AE-COPD组中,41.9%的患者鉴定出呼吸道病毒,在CP-COPD组中这一比例为33.5%。AE-COPD组中最常见的病毒是流感病毒(33.7%),而CP-COPD组中最常见的是人类冠状病毒(24.1%)。AE-ACOPD组中流感病毒的发生率显著高于CP-COPD组(P < 0.01)。AE-COPD和CP-COPD的住院死亡率分别为1.2%和12.3%(P < 0.01)。在CP-COPD患者中,仅病毒感染组、仅细菌感染组和病毒-细菌混合感染组的住院死亡率分别为2.6%、25.8%和17.5%(P = 0.01)。AE-COPD和CP-COPD患者中均普遍鉴定出呼吸道病毒,流感病毒和人类冠状病毒分别是AE-COPD和CP-COPD患者中最常见的病毒。CP-COPD患者中仅病毒感染组的死亡率显著低于仅细菌感染组或病毒-细菌混合感染组。《医学病毒学杂志》88:2092 - 2099,2016年。© 2016威利期刊公司